Tania Moccia

957 total citations
17 papers, 685 citations indexed

About

Tania Moccia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tania Moccia has authored 17 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tania Moccia's work include Histone Deacetylase Inhibitors Research (6 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Tania Moccia is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Epigenetics and DNA Methylation (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). Tania Moccia collaborates with scholars based in Italy, Greenland and Denmark. Tania Moccia's co-authors include Alfredo Budillon, Carmine Carbone, James L. Abbruzzese, Davide Melisi, Paul J. Chiao, Vincenzo Marotta, Anna Guerra, Stefania Rossi, Mario Vitale and Laura Fugazzola and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Tania Moccia

17 papers receiving 684 citations

Peers

Countries citing papers authored by Tania Moccia

Since Specialization

Citations

This map shows the geographic impact of Tania Moccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Moccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Moccia more than expected).

Fields of papers citing papers by Tania Moccia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Moccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Moccia. The network helps show where Tania Moccia may publish in the future.

Co-authorship network of co-authors of Tania Moccia

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Moccia. A scholar is included among the top collaborators of Tania Moccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Moccia. Tania Moccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer 2025 ·Cell Death and Disease ·Maria Serena Roca, Rita Lombardi, Cristina Testa, Federica Iannelli, (unknown), Tania Moccia, (unknown), (unknown), Domenico Memoli, Alessandra Leone, Simone Di Franco, Giorgio Stassi, Antonio Avallone, Francesca Bruzzese, Biagio Pucci, Alfredo Budillon, Elena Di Gennaro	1
2	Abstract 1700: Valproic acid potentiates the efficacy of anti-EGFR monoclonal antibodies in sensitive and resistant RAS/BRAF wild type colorectal cancer models 2025 ·Cancer Research ·Roberta Affatato, Elena Di Gennaro, Alessandra Leone, Biagio Pucci, (unknown), Rita Lombardi, (unknown), Maria Serena Roca, Francesca Bruzzese, Francesca Collina, Claudia Cardone, Tania Moccia, (unknown), Antonio Avallone, Alfredo Budillon	1
3	HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation 2022 ·Journal of Experimental & Clinical Cancer Research ·Maria Serena Roca, Tania Moccia, Federica Iannelli, Cristina Testa, Carlo Vitagliano, Michele Minopoli, Rosa Camerlingo, Giulia De Riso, Rossella De Cecio, Francesca Bruzzese, Mariarosaria Conte, Lucia Altucci, Elena Di Gennaro, Antonio Avallone, Alessandra Leone, Alfredo Budillon	36
4	Abstract 1840: Repurposing of valproic acid and simvastatin in pancreatic cancer: in vitro and in vivo synergistic antitumor interaction and sensitization to gemcitabine/nab-paclitaxel via inhibition of TGFβ-EMT signaling pathway 2022 ·Cancer Research ·Maria Serena Roca, Federica Iannelli, (unknown), (unknown), Cristina Testa, Tania Moccia, Carlo Vitagliano, Fabiana Tatangelo, (unknown), Antonio Avallone, Francesca Bruzzese, Alessandra Leone, Alfredo Budillon	1
5	Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance 2020 ·Frontiers in Cell and Developmental Biology ·Federica Iannelli, (unknown), Maria Serena Roca, (unknown), Rita Lombardi, Tania Moccia, Carlo Vitagliano, Maria Rita Milone, Chiara Ciardiello, Francesca Bruzzese, Alessandra Leone, Ernesta Cavalcanti, Rossella De Cecio, Giuseppina Iachetta, Salvatore Valiante, Franco Ionna, Francesco Caponigro, Elena Di Gennaro, Alfredo Budillon	25
6	Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition 2020 ·Journal of Experimental & Clinical Cancer Research ·Federica Iannelli, Maria Serena Roca, Rita Lombardi, Chiara Ciardiello, (unknown), (unknown), Tania Moccia, Carlo Vitagliano, (unknown), Susan Costantini, Maria Rita Milone, Biagio Pucci, Alessandra Leone, Elena Di Gennaro, Rita Mancini, Gennaro Ciliberto, Francesca Bruzzese, Alfredo Budillon	45
7	HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer 2020 ·Molecular Oncology ·Rita Lombardi, Maura Sonego, Biagio Pucci, (unknown), Federica Iannelli, Francesca Capone, Luigi Alfano, Maria Serena Roca, Maria Rita Milone, Tania Moccia, (unknown), Elena Di Gennaro, Francesca Bruzzese, Gustavo Baldassarre, Alfredo Budillon	13
8	Abstract 2877: Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting cancer stem cells compartment via YAP-pathway modulation 2018 ·Cancer Research ·Federica Iannelli, Maria Serena Roca, Chiara Ciardiello, (unknown), Rita Lombardi, (unknown), Susan Costantini, Tania Moccia, Maria Rita Milone, Biagio Pucci, Alfredo Budillon, Francesca Bruzzese	1
9	Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression 2016 ·Oncotarget ·Chiara Ciardiello, Maria Serena Roca, Alessia Noto, Francesca Bruzzese, Tania Moccia, Carlo Vitagliano, Elena Di Gennaro, Gennaro Ciliberto, Giuseppe Roscilli, Luigi Aurisicchio, Emanuele Marra, Rita Mancini, Alfredo Budillon, Alessandra Leone	17
10	Indices of methylation in sperm DNA from fertile men differ between distinct geographical regions 2014 ·Human Reproduction ·Claudia Consales, Giorgio Leter, Jens Peter Bonde, Gunnar Toft, Patrizia Eleuteri, Tania Moccia, Alfredo Budillon, Bo Jönsson, Aleksander Giwercman, Henning Sloth Pedersen, Jan K Ludwicki, Valentyna Zviezdai, Dick Heederik, Maria Spano	16
11	Exposure to Perfluoroalkyl Substances and Sperm DNA Global Methylation in Arctic and European Populations 2014 ·Environmental and Molecular Mutagenesis ·Giorgio Leter, Claudia Consales, Patrizia Eleuteri, Raffaella Uccelli, Ina Olmer Specht, Gunnar Toft, Tania Moccia, Alfredo Budillon, Bo Jönsson, Christian Lindh, Aleksander Giwercman, Henning Sloth Pedersen, Jan K Ludwicki, Valentyna Zviezdai, Dick Heederik, Jens Peter Bonde, Marcello Spanò	47
12	A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 2012 ·The Journal of Clinical Endocrinology & Metabolism ·Anna Guerra, Laura Fugazzola, Vincenzo Marotta, Massimo Círillo, Stefania Rossi, Valentina Cirello, Irene Forno, Tania Moccia, Alfredo Budillon, Mario Vitale	109
13	Abstract LB-219: Neoadjuvant multidisciplinary phase II study (BRANCH) of an early bevacizumab schedule plus chemo-radiation therapy in rectal cancer: efficacy, safety, and biomarkers. 2012 ·Cancer Research ·Antonio Avallone, Elena Di Gennaro, Paolo Delrio, Luigi Aloj, Fabiana Tatangelo, Biagio Pecori, Alessandra Leone, Corradina Caracò, Tania Moccia, Vincenzo Rosario Iaffaioli, G. Romano, Secondo Lastoria, Alfredo Budillon	3
14	Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype 2011 ·Clinical Cancer Research ·Carmine Carbone, Tania Moccia, Cihui Zhu, (unknown), Alfredo Budillon, Paul J. Chiao, James L. Abbruzzese, Davide Melisi	80
15	The Primary Occurrence ofBRAF^V600EIs a Rare Clonal Event in Papillary Thyroid Carcinoma 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Anna Guerra, Maria Rosaria Sapio, Vincenzo Marotta, (unknown), Stefania Rossi, Irene Forno, Laura Fugazzola, Alfredo Budillon, Tania Moccia, Gianfranco Fenzi, Mario Vitale	121
16	Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1 2011 ·JNCI Journal of the National Cancer Institute ·Davide Melisi, Qianghua Xia, (unknown), Jianhua Ling, Tania Moccia, Carmine Carbone, Alfredo Budillon, James L. Abbruzzese, Paul J. Chiao	133
17	Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase 2010 ·British Journal of Cancer ·Elena Di Gennaro, Geny Piro, (unknown), Renato Franco, (unknown), Tania Moccia, Antonio Luciano, Immacolata Ruggiero, Francesca Bruzzese, Antonio Avallone, Claudio Arra, Alfredo Budillon	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact